Chromosome 22q11 and schizophrenia

Soh Agatsuma, Noboru Hiroi

Research output: Contribution to journalReview article

Abstract

Several human chromosomal regions have been identified as candidate regions that play a role in schizophrenia. Deletion or duplication of chromosome 22q11 is associated with velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS), a disorder associated with high rates of schizophrenia as well as physical abnormalities (i.e., cardiovascular, parathyroid, thymic and craniofacial abnormalities). Recent mouse studies have identified several candidate genes for VCFS/DGS within the mouse homologue chromosome 16. Deletion of Tbx1, Prodh and Comt within mouse chromosome 16 causes several physical and behavioral features of VCFS/DGS. As VCFS/DGS is likely to represent a genetic subtype of schizophrenia, pinpointing the genetic basis for this specific subtype will contribute to a better understanding of this neuropsychiatric disorder.

Original languageEnglish (US)
Pages (from-to)79-84
Number of pages6
JournalJapanese Journal of Neuropsychopharmacology
Volume25
Issue number2
StatePublished - Apr 1 2005

Keywords

  • Chromosome 22q11
  • Schizophrenia
  • VCFS/DGS

ASJC Scopus subject areas

  • Clinical Psychology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Chromosome 22q11 and schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Agatsuma, S., & Hiroi, N. (2005). Chromosome 22q11 and schizophrenia. Japanese Journal of Neuropsychopharmacology, 25(2), 79-84.